This is a limited company view. Sign up for a Free Trial to see everything.

Symetis is a Swiss company developing minimally invasive heart valve replacement therapies for patients suffering from heart valve diseases.

B2B
Biotechnology
Cleantech
Healthcare
Medical Devices
Medical Diagnostics
Pharmaceuticals
Wind Power

Overview

Location

Ecublens

Founded

Employees

118

Stage

Series C

Total funding

$26M

Last funding

7 years ago

Acquisitions

0

Growth score

125

Mindshare score

85

Scoring

Deals

$25.8M Series C

Endeavour Vision

Oct 8, 2010

Other Investors

NBGI Ventures

Employee Growth

Use Symetis's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Symetis's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

PA to the CEO
Marketing Director Europe
Senior Regional Sales Director
Vice President Sales and Marketing Europe
Business Development Manager
VP Finance
Clinical Director
Quality System Manager
R&D Project Manager
Clinical Project Manager
Manufacturing Manager
Site Director
RD Manager
Account-Manager TAVI
Product Manager
Director Marketing
Account Manager Switzerland
Director HR

Similar Companies

ESBATech

ESBATech develops fully human antibody fragments for therapeutic applications, applying the single-chain antibody framework.
Acquired|48 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes